Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens-Reference-Cited by-同舟云学术

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

Published:2017-10-06 Issue:2 Volume:19 Page:102-117
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Cozzi-Lepri A¹,Zangerle R²,Machala L³,Zilmer K⁴,Ristola M⁵,Pradier C⁶,Kirk O⁷,Sambatakou H⁸,Fätkenheuer G⁹¹⁰,Yust I¹¹,Schmid P¹²,Gottfredsson M¹³,Khromova I¹⁴,Jilich D¹⁵,Flisiak R¹⁶,Smidt J¹⁷,Rozentale B¹⁸,Radoi R¹⁹,Losso MH²⁰,Lundgren JD⁷,Mocroft A¹,

Affiliation:

1. Centre for Clinical Research, Modelling and Epidemiology; Research Department of Infection and Population Health; Institute for Global Health; University College London Medical School; Royal Free Campus London UK

2. Medical University Innsbruck; Innsbruck Austria

3. Department of Infectious and Tropical Diseases; Third Faculty of Medicine; Charles University and Na Bulovce Hospital; Prague Czech Republic

4. West-Tallinn Central Hospital; Tallinn Estonia

5. Helsinki University Hospital; Helsinki Finland

6. L'Archet 1 Hospital; University of Nice Sophia-Antipolis; Nice France

7. Rigshospitalet; University of Copenhagen; Copenhagen Denmark

8. Ippokration General Hospital; Athens Greece

9. Department of Internal Medicine 1; University Hospital of Cologne; Cologne Germany

10. German Center for Infection Research (DZIF); Partner Site Bonn-Cologne; Cologne Germany

11. Ichilov Hospital; Tel Aviv-Yafo Israel

12. Kantonsspital St. Gallen; St. Gallen Switzerland

13. Faculty of Medicine; School of Health Sciences; University of Iceland; Reykjavik, Iceland and Landspitali University Hospital; Reykjavík Iceland

14. Centre for HIV/AIDS and infectious diseases; Kaliningrad Russian Federation

15. Department of Infectious and Tropical Diseases; First Faculty of Medicine; Charles University and Na Bulovce Hospital; Prague Czech Republic

16. Department of Infectious Diseases and Hepatology; Medical University of Bialystok; Bialystok Poland

17. Ida-Viru Central Hospital; Kohtla-Jarve

18. Infectology Center of Latvia; Riga Latvia

19. Dr. Victor Babes Hospital; Bucureşti Romania

20. Hospital J.M. Ramos Mejia; Buenos Aires Argentina

Funder

Seventh Framework Programme

Bristol-Myers Squibb

Gilead Sciences

GlaxoSmithKline

Janssen Research and Development

Merck

Pfizer

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Danmarks Grundforskningsfond

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12557/fullpdf

Reference39 articles.

1. Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies;Burger;Expert Opin Drug Metab Toxicol,2010

2. HIV integrase inhibitors in ART-experienced patients;Blanco;Curr Opin HIV AIDS,2012

3. Pharmacology of HIV integrase inhibitors;Adams;Curr Opin HIV AIDS,2012

4. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents http://www.aidsinfo.nih.gov/guidelines

5. Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort;Wittkop;J Antimicrob Chemother,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIs versus NNRTIs and the Risk of Cancer among People with HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-23

2. Immune restoration affects 10‐year survival in people living with HIV / AIDS;HIV Medicine;2022-08-25

3. Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting;Open Forum Infectious Diseases;2022-01-19

4. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs;Frontiers in Oncology;2020-05-21

5. HIV‐1, HAART and cancer: A complex relationship;International Journal of Cancer;2020-05-15